Past Conferences
KEYNOTE AND PANELISTS
PRESENTING COMPANIES
Media
SPONSORS

2018 Bloom Burton & Co. Healthcare Investor Conference
May 2-3, 2018

Sheraton Centre Toronto Hotel - 123 Queen St W.

THE CONFERENCE

2018 KEYNOTE SPEAKERS AND PANELISTS

John D. Carroll
Endpoints News

John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 15 years. Aside from his daily industry coverage for FierceBiotech, where he was named editor in 2003, leaving in 2016, Carroll has been a regular speaker at biotech events around the globe. He’s been quoted by The New York Times, The New Yorker, Financial Times, The Times of London and more. He’s also keynoted at biotech gatherings around the world and addressed student audiences at MIT and Harvard. Carroll has contributed stories from Central America and Ireland to the Dallas Morning News and Time and wrote for the Houston Press. He spent 6 years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at the Kansas City Star & Times.

Endpoints News is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day.

Rajeev Shah
RA Capital Management

Rajeev Shah is a Managing Director and Portfolio Manager at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life sciences. Raj is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. He is also active in the firm’s outreach efforts, speaking frequently both at industry events and in classrooms. Raj holds a BS from Cornell University, where he majored in Chemistry with a concentration in Economics. Raj previously worked as a Senior Project Leader at Altus Pharmaceuticals, a spin-off company of Vertex Pharmaceuticals, where he assessed business processes and implemented system solutions across all areas of science. He is also an active member of the Big Brothers of Massachusetts Bay program.

RA Capital Management (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics.

Investing in R&D-Stage Healthcare Companies

Paulina
Hill
Polaris Partners
Ting
Jia
Hillhouse Capital Management
Daniel
Krizek
Surveyor Capital
Stacey
Seltzer
Aisling Capital
Caroline
Stout
EcoR1 Capital

Investing in Commercial-Stage Healthcare Companies

Ruoxi
Chen
Healthcare, Warburg Pincus
Jeffrey
Schwartz
Bain Capital Life Sciences
Thecla
Sweeney
Birch Hill Equity Partners
Tadd
Wessel
Petrichor Healthcare Capital Management
Jason
Wild
JW Asset Management

PRESENTING COMPANIES